Accuracy and reproducibility of simplified QSPECT dosimetry for personalized 177Lu-octreotate PRRT
Abstract Background Routine dosimetry is essential for personalized 177Lu-octreotate peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors (NETs), but practical and robust dosimetry methods are needed for wide clinical adoption. The aim of this study was to assess the accuracy and in...
Main Authors: | Michela Del Prete, Frédéric Arsenault, Nassim Saighi, Wei Zhao, François-Alexandre Buteau, Anna Celler, Jean-Mathieu Beauregard |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2018-10-01
|
Series: | EJNMMI Physics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40658-018-0224-9 |
Similar Items
-
Impact of dead time on quantitative 177Lu-SPECT (QSPECT) and kidney dosimetry during PRRT
by: Alessandro Desy, et al.
Published: (2020-05-01) -
Salvage PRRT with 177Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival
by: S. Rudisile, et al.
Published: (2019-08-01) -
Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy
by: Anna Sundlöv, et al.
Published: (2018-07-01) -
In Vivo Measurement and Characterization of a Novel Formulation of [177Lu]-DOTA-Octreotate
by: Dale Bailey, et al.
Published: (2016-01-01) -
177Lu-DOTA-0-Tyr3-octreotate infusion modeling for real-time detection and characterization of extravasation during PRRT
by: Christophe Mazzara, et al.
Published: (2022-05-01)